AIM ImmunoTech CEO Webinar June 24; CelLBxHealth Guides 50% Revenue Growth
AIM•AIM ImmunoTech will host CEO Thomas Equels for a live 20-minute presentation in the Webull Corporate Connect Webinar Series on June 24 at 2:40 PM ET. CelLBxHealth, listed on AIM, forecasts at least £2.1 million in 2026 revenue, up 50% from £1.4 million, backed by a 22% quarter-on-quarter partnership pipeline expansion.
1. AIM ImmunoTech Webinar Presentation
AIM ImmunoTech announced that CEO Thomas Equels will present in the Webull Corporate Connect Webinar Series on Wednesday, June 24 from 2:40 to 3:00 PM ET. The live webcast will cover the company’s immuno-pharma pipeline developments and strategic priorities to a global retail investor audience.
2. CelLBxHealth Revenue Guidance
CelLBxHealth, trading on the AIM market, has issued guidance for at least £2.1 million in revenue for fiscal 2026, representing a 50% increase from £1.4 million in 2025. This outlook is underpinned by a 22% expansion in its pharmaceutical and diagnostic partnership pipeline during the last quarter after cost-base reductions and leadership restructuring.
